Article
Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate.
PloS one - 1 Jan 2013
Gao Lichen, He Yijing, Tang Jie, Yin Jiye, Huang Zhengyu, Liu Fangqun, Ouyang Dongsheng, Chen Xiaoping, Zhang Wei, Liu Zhaoqian, Zhou Honghao
Abstract excerpt
UNLABELLED: This study investigated the effects of pregnane X receptor (PXR/NR1I2) and CYP2B6 genetic variants on sodium ferulate (SF)-mediated induction of bupropion hydroxylation. The pharmacokinetics of bupropion and hydroxybupropion were evaluated after an oral dose of bupropion (150 mg) administered with and without SF pretreatment for 14 days in 33 healthy subjects. The area under the time-concentration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
